On February 16, 2022, Salona Global Medical Device Corporation ("Salona" or "the Company") closed an approximately C$4.26 million offering on a bought deal private placement financing (the “Offering”). A total of 7,749,000 Units were sold at a price of C$0.55 per Unit.
The Offering was underwritten by a syndicate of underwriters led by Beacon Securities Limited ("Beacon") and included Canaccord Genuity Corp. and Leede Jones Gable Inc. Each Unit consists of one common share of the Company (each, a “Common Share”) and one Common Share purchase warrant (each, a “Warrant”), with each Warrant entitling the holder to acquire one Common Share at a price C$0.70 for a period of 36 months after the closing date of the Offering.
Fasken advised Beacon Securities with a team led by John Sabetti and including Rubin Rapuch, Zach Austin, Matthew Rebus and Mitchell Thaw (Tax).
Jurisdiction
- Ontario
